PD 131628
| Code | Size | Price |
|---|
| TAR-T33899-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T33899-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T33899-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
PD 131628 is a novel fluoroquinolone that is a bioactive form of PD 131112 or CI-990 for use against anaerobic bacteria.
CAS:
127967-03-7
Formula:
C16H17FN4O3
Molecular Weight:
332.335
Purity:
0.98
SMILES:
N[C@H]1CCN(C1)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1
References
Sewell DL, Barry AL, Allen SD, Fuchs PC, Murray PR, Tenover FC. Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116)). J Antimicrob Chemother. 1996 Jan;37(1):139-43. PubMed PMID: 8647755.
Wexler HM, Molitoris E, Reeves D, Finegold SM. In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria. J Antimicrob Chemother. 1994 Oct;34(4):579-84. PubMed PMID: 7868409.
Barry AL, Fuchs PC, Citron DM, Allen SD, Wexler HM. Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin. J Antimicrob Chemother. 1993 Jun;31(6):893-900. PubMed PMID: 8395494.
Qadri SM, Ueno Y. Susceptibility of Brucella melitensis to the new fluoroquinolone PD 131628: comparison with other drugs. Chemotherapy. 1993 Mar-Apr;39(2):128-31. PubMed PMID: 8384544.